79 related articles for article (PubMed ID: 26740967)
21. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
[TBL] [Abstract][Full Text] [Related]
22. Isoproterenol Increases RANKL Expression in a ATF4/NFATc1-Dependent Manner in Mouse Osteoblastic Cells.
Baek K; Park HJ; Baek JH; Kim HR
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053621
[TBL] [Abstract][Full Text] [Related]
23. Sp1 Mediates the Constitutive Expression and Repression of the PDSS2 Gene in Lung Cancer Cells.
Hu L; Chen Q; Wang Y; Zhang N; Meng P; Liu T; Bu Y
Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31783675
[TBL] [Abstract][Full Text] [Related]
24. MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?
Abbas HHK; Alhamoudi KMH; Evans MD; Jones GDD; Foster SS
BMC Cancer; 2018 Apr; 18(1):423. PubMed ID: 29661172
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of KLF5 promotes cisplatin-induced cell apoptosis via regulating DNA damage checkpoint proteins in non-small cell lung cancer.
Zhang H; Shao F; Guo W; Gao Y; He J
Thorac Cancer; 2019 May; 10(5):1069-1077. PubMed ID: 30900384
[TBL] [Abstract][Full Text] [Related]
26. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene.
Pang RT; Lee LT; Ng SS; Yung WH; Chow BK
Mol Endocrinol; 2004 Feb; 18(2):471-83. PubMed ID: 14645499
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling.
Akimzhanov A; Krenacs L; Schlegel T; Klein-Hessling S; Bagdi E; Stelkovics E; Kondo E; Chuvpilo S; Wilke P; Avots A; Gattenlöhner S; Müller-Hermelink HK; Palmetshofer A; Serfling E
Am J Pathol; 2008 Jan; 172(1):215-24. PubMed ID: 18156209
[TBL] [Abstract][Full Text] [Related]
28. CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer.
Zhang P; Wang J; Gao W; Yuan BZ; Rogers J; Reed E
Mol Cancer; 2004 May; 3():14. PubMed ID: 15125777
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
30. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
31. Involvement of PU.1 in NFATc1 promoter function in osteoclast development.
Ishiyama K; Yashiro T; Nakano N; Kasakura K; Miura R; Hara M; Kawai F; Maeda K; Tamura N; Okumura K; Ogawa H; Takasaki Y; Nishiyama C
Allergol Int; 2015 Jul; 64(3):241-7. PubMed ID: 26117255
[TBL] [Abstract][Full Text] [Related]
32. The 5'-upstream region of human programmed cell death 5 gene contains a highly active TATA-less promoter that is up-regulated by etoposide.
Xu M; Cheng N; Gui L; Lai M; Wang Y; Xia D; Rui M; Zhang Y; Ma D
Gene; 2004 Mar; 329():39-49. PubMed ID: 15033527
[TBL] [Abstract][Full Text] [Related]
33. A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells.
Guo D; Wu B; Yan J; Li X; Sun H; Zhou D
Biochem Biophys Res Commun; 2012 Nov; 428(1):80-5. PubMed ID: 23047008
[TBL] [Abstract][Full Text] [Related]
34. IL-4-mediated transcriptional regulation of human CYP2E1 by two independent signaling pathways.
Wang J; Hu Y; Nekvindova J; Ingelman-Sundberg M; Neve EP
Biochem Pharmacol; 2010 Nov; 80(10):1592-600. PubMed ID: 20723539
[TBL] [Abstract][Full Text] [Related]
35. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
36. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
[TBL] [Abstract][Full Text] [Related]
37. NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2.
Wang L; Wang Z; Li J; Zhang W; Ren F; Yue W
Int J Mol Med; 2015 May; 35(5):1333-40. PubMed ID: 25738651
[TBL] [Abstract][Full Text] [Related]
38. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma.
Sun CQ; Arnold R; Fernandez-Golarz C; Parrish AB; Almekinder T; He J; Ho SM; Svoboda P; Pohl J; Marshall FF; Petros JA
Cancer Res; 2006 Sep; 66(17):8542-9. PubMed ID: 16951166
[TBL] [Abstract][Full Text] [Related]
39. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM
Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536
[TBL] [Abstract][Full Text] [Related]
40. Acquired expression of NFATc1 downregulates E-cadherin and promotes cancer cell invasion.
Oikawa T; Nakamura A; Onishi N; Yamada T; Matsuo K; Saya H
Cancer Res; 2013 Aug; 73(16):5100-9. PubMed ID: 23811942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]